Loading
Institute for Stem Cell Science and Regenerative Medicine
A Department of Biotechnology institute in Bengaluru that develops stem cell and gene editing approaches to cancer and blood disorders, and shares a campus with NCBS.
Also called: inStem
Overview
inStem was established in 2009 as an autonomous institute of the Department of Biotechnology and now sits under the Biotechnology Research and Innovation Council. Its stated focus is cellular therapies for cancer, cardiovascular and neurodegenerative disease, using stem cell biology, disease modelling, CRISPR-based gene editing and bioinformatics. It is part of the Bangalore Life Science Cluster with NCBS and C-CAMP, collaborates with CMC Vellore's Centre for Stem Cell Research on haematological gene therapy, and had a budget of about 60.6 crore rupees in 2022-23.
Location
Bengaluru, IN
Type
research institute
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#376 · 16 points (0 Newsweek + 0 NCI + 16 from 8 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-08.
Matched to Institute for Stem Cell Biology and Regenerative Medicine, including child institutions. 4 works · 116 citations · 75% open access · 0% clinical trials · 0% reviews.
Oncology works per year
32022
02023
12024
02025
02026
Most works
- Rajbir Singh2 works
- Sweta Ghosh2 works
- Venkatakrishna Rao Jala2 works
- Praveen Kumar Vemula2 works
- Bodduluri Haribabu2 works
- Haixun Guo2 works
- Ajay Goel2 works
- Krithika Badarinath1 works
- Chaiyong Koaykul1 works
- Zachary M. Vanwinkle1 works
Most cited
| Work | Journal | Year | Citations |
|---|---|---|---|
| Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis 10.7150/thno.70754 · open access | Theranostics | 2022 | 85 |
| Snail maintains the stem/progenitor state of skin epithelial cells and carcinomas through the autocrine effect of matricellular protein Mindin 10.1016/j.celrep.2022.111390 · open access | Cell Reports | 2022 | 16 |
| Challenges in Global Access to CAR-T cells: an Asian Perspective 10.31547/bct-2023-023 · open access | BLOOD CELL THERAPY / The official journal of APBMT | 2024 | 13 |
| Abstract 3250: Microbial metabolite, Urolithin A acts as chemo-sensitizing adjuvant in conventional drug therapies via modulation of drug transporters and EMT markers conference abstract · 10.1158/1538-7445.am2022-3250 | Cancer Research | 2022 | 2 |
Programmes
3- Stem cell biology and disease modelling
- CRISPR gene editing
- Cell therapy translation
People
1Connected
9Similar pages
fronts
technologies
institutions
people
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
res.in · 1
A source that has moved or gone is reported by the weekly link check. /audit/
ProvenanceLast edited 2026-09-11 · Jude Gomila · Link wave 4 leaders and trialists from their institutions… · diff · file
Sourced, not expert-reviewed